Basics MaxCyte, Inc. Common Stock IPO Date: July 26, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $182.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.03% Avg Daily Range (30 D): $0.07 | 4.20% Avg Daily Range (90 D): $0.06 | 3.28% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): .63M Avg Daily Volume (90 D): .66M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 148 Avg Trade Size (Sh.) (90 D): 147 Institutional Trades Total Inst.Trades: 162 Avg Inst. Trade: $2.33M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $.9M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.16M Avg Closing Trade (30 D): $.7M Avg Closing Trade (90 D): $.7M Avg Closing Volume: 518.3K     News Jul 4, 2024 @ 1:11 PM Global Transfection Technologies Market Predicted ... Source: Polaris Market Research (Pmr) Jun 13, 2024 @ 1:55 PM Does MaxCyte (MXCT) Have the Potential to Rally 85... Source: Zacks Equity Research Jun 13, 2024 @ 12:50 PM Recent Price Trend in MaxCyte (MXCT) is Your Frien... Source: Zacks Equity Research May 29, 2024 @ 12:05 PM MaxCyte to Participate in William Blair 44th Annua... Source: MaxCyte, Inc May 22, 2024 @ 12:05 PM MaxCyte Signs Strategic Platform License Agreement... Source: MaxCyte, Inc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.42 $-.12 $-.1 Diluted EPS $-.42 $-.12 $-.09 Revenue $ 35.75M $ 8.51M $ 10.39M Gross Profit $ 28.53M $ 6.99M $ 8.89M Net Income / Loss $ -44.77M $ -12.36M $ -10.26M Operating Income / Loss $ -53.48M $ -14.23M $ -12.3M Cost of Revenue $ 7.23M $ 1.52M $ 1.5M Net Cash Flow $ -22.29M $ -8.16M $ -4.5M PE Ratio